Alvotech (ALVO)

Alvotech (ALVO) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.9B; returns 1 day -4.4%, 1 week -8.4%, 1 year -43.8%.

Alvotech is a global biotech company specializing in the development and manufacture of biosimilar medicines. Headquartered in Reykjavik, Iceland, and founded in 2013, Alvotech focuses on creating cost-effective alternatives to existing biologic drugs, primarily in therapeutic areas like oncology, immunology, and diabetes.

Groups ALVO belongs to

• Biotechnology
• Biologics
• Healthcare
• Pharmaceuticals
• Manufacturing
• Commercial Stage
• Vertical Integration
• Commercial Stage Biotech
• R&D
• Immunotherapy
• Autoimmune Diseases

ALVO financial model: income statement, cash flow and balance sheet